Showing results (151-160 of 279) with videos related to
Sort By:
Pageof 28
Frontiers in Oncology|November 8, 2024
Pre-malignant conditions diagnosed following a positive cancer signal from a multi-cancer early detection testOmair A Choudhry, Angana B Kharge, Seema P Rego, et al.Journal of the American Geriatrics Society|March 7, 2017
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyKerri M Winters-Stone, Esther Moe, Julie N Graff, et al.Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.European Urology|June 13, 2020
Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL TrialAndrew J Armstrong, Ping Lin, Bertrand Tombal, et al.European Urology Oncology|December 28, 2023
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant ChemotherapyPetros Grivas, Vadim S Koshkin, Xiangying Chu, et al.British Journal of Haematology|September 21, 2006
High dose calcitriol may reduce thrombosis in cancer patientsTomasz M Beer, Peter M Venner, Christopher W Ryan, et al.Cancer|October 27, 2007
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxelTomasz M Beer, Christopher W Ryan, Peter M Venner, et al.Magnetic Resonance in Medicine|March 30, 2012
Feasibility of shutter-speed DCE-MRI for improved prostate cancer detectionXin Li, Ryan A Priest, William J Woodward, et al.Cancer Causes & Control : CCC|April 13, 2010
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older menChristine M Barnett, Carrie M Nielson, Jackie Shannon, et al.Pageof 28